Synjardy (Empagliflozin and Metformin Hydrochloride) 500 mg Tablet

Synjardy 500 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

Synjardy 500 mg/1 tablets are designed to help manage type 2 diabetes by improving blood sugar levels. This combination medication works by increasing insulin sensitivity and reducing glucose absorption in the kidneys. It is typically used alongside diet and exercise to achieve better glycemic control.

Common effects of Synjardy 500 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some users might experience dizziness or headache. These effects vary and are not experienced by everyone.

Synjardy 500 mg/1 tablets should be used with caution in individuals with kidney issues or a history of lactic acidosis. It is important to stay hydrated and monitor blood sugar levels regularly. Consult a healthcare provider before use.

Synjardy 500 mg/1 tablets may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol and some over-the-counter medications can also affect its efficacy. Always inform your healthcare provider about all medications you are taking.